# Myovant Sciences Ltd. (MYOV)

Source: https://www.quantisnow.com/company/MYOV
Generated: 2026-11-14T22:47:20.883Z

- Ticker: MYOV
- Exchange: NYSE
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2016
- Website: myovant.com

## About

Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, for the treatment of female infertility as part of assisted reproduction and is under phase 2 clinical trial. Myovant Sciences Ltd. has collaboration with Pfizer Inc. to develop and commercialize relugolix in oncology and women's health. The company was formerly known as Roivant Endocrinology Ltd. and changed its name to Myovant Sciences Ltd. in May 2016. The company was incorporated in 2016 and is based in London, the United Kingdom. Myovant Sciences Ltd. operates as a subsidiary of Sumitovant Biopharma Ltd.

## Latest MYOV news and filings

- 2023-03-20 17:58 UTC [SEC Form 15-12G filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-myovant-sciences-ltd-4224510)
- 2023-03-17 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-myovant-sciences-ltd-4215768)
- 2023-03-17 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-myovant-sciences-ltd-4215753)
- 2023-03-10 18:11 UTC [SEC Form 25-NSE filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-myovant-sciences-ltd-4186332)
- 2023-03-10 14:32 UTC [SEC Form 4] [SEC Form 4: Valente Nancy returned 3,673 shares to the company, closing all direct ownership in the company (withholding obligation)](https://www.quantisnow.com/insight/sec-form-4-valente-nancy-returned-3673-shares-to-the-4184957)
- 2023-03-10 14:32 UTC [SEC Form 4] [SEC Form 4: Potter Myrtle S returned 3,673 shares to the company, closing all direct ownership in the company to satisfy tax liability](https://www.quantisnow.com/insight/sec-form-4-potter-myrtle-s-returned-3673-shares-to-4184954)
- 2023-03-10 14:31 UTC [SEC Form 4] [SEC Form 4: Merendino Lauren returned 169,538 shares to the company, closing all direct ownership in the company to satisfy withholding tax](https://www.quantisnow.com/insight/sec-form-4-merendino-lauren-returned-169538-shares-to-the-4184949)
- 2023-03-10 14:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-myovant-sciences-ltd-4184946)
- 2023-03-10 14:31 UTC [SEC Form 4] [SEC Form 4: Mehra Uneek returned 202,696 shares to the company, closing all direct ownership in the company (for tax liability)](https://www.quantisnow.com/insight/sec-form-4-mehra-uneek-returned-202696-shares-to-the-4184943)
- 2023-03-10 14:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-myovant-sciences-ltd-4184941)
- 2023-03-10 14:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-myovant-sciences-ltd-4184940)
- 2023-03-10 14:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-myovant-sciences-ltd-4184939)
- 2023-03-10 14:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-myovant-sciences-ltd-4184938)
- 2023-03-10 14:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-myovant-sciences-ltd-4184937)
- 2023-03-10 14:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-myovant-sciences-ltd-4184935)
- 2023-03-10 14:30 UTC [SEC Form 4] [SEC Form 4: Marek David C returned 417,599 shares to the company, closing all direct ownership in the company to satisfy withholding tax](https://www.quantisnow.com/insight/sec-form-4-marek-david-c-returned-417599-shares-to-4184925)
- 2023-03-10 14:29 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Myovant Sciences Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-myovant-sciences-ltd-amendment-4184915)
- 2023-03-10 14:29 UTC [SEC Form POS AM filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-myovant-sciences-ltd-4184914)
- 2023-03-10 14:29 UTC [SEC Form POS AM filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-myovant-sciences-ltd-4184912)
- 2023-03-10 14:29 UTC [SEC Form 4] [SEC Form 4: Lang Matthew returned 354,303 shares to the company, closing all direct ownership in the company (for withholding tax)](https://www.quantisnow.com/insight/sec-form-4-lang-matthew-returned-354303-shares-to-the-4184911)
- 2023-03-10 14:28 UTC [SEC Form 4] [SEC Form 4: Gulfo Adele M. returned 3,673 shares to the company, closing all direct ownership in the company to satisfy withholding obligation](https://www.quantisnow.com/insight/sec-form-4-gulfo-adele-m-returned-3673-shares-to-4184896)
- 2023-03-10 14:28 UTC [SEC Form 4] [SEC Form 4: Guinan Mark returned 3,673 shares to the company, closing all direct ownership in the company to satisfy tax liability](https://www.quantisnow.com/insight/sec-form-4-guinan-mark-returned-3673-shares-to-the-4184891)
- 2023-03-10 14:27 UTC [SEC Form 4] [SEC Form 4: Curran Terrie returned 3,673 shares to the company, closing all direct ownership in the company to satisfy withholding obligation](https://www.quantisnow.com/insight/sec-form-4-curran-terrie-returned-3673-shares-to-the-4184889)
- 2023-03-10 14:26 UTC [SEC Form SC 13E3/A filed by Myovant Sciences Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-myovant-sciences-ltd-amendment-4184881)
- 2023-03-10 14:24 UTC [SEC Form 4] [SEC Form 4: Arjona Ferreira Juan Camilo returned 246,684 shares to the company, closing all direct ownership in the company to satisfy withholding obligation](https://www.quantisnow.com/insight/sec-form-4-arjona-ferreira-juan-camilo-returned-246684-shares-4184874)
- 2023-03-10 14:17 UTC [SEC Form 4] [SEC Form 4: Sumitomo Chemical Co., Ltd. bought $1,393,178,400 worth of shares (51,599,200 units at $27.00)](https://www.quantisnow.com/insight/sec-form-4-sumitomo-chemical-co-ltd-bought-1393178400-worth-4184846)
- 2023-03-10 14:10 UTC [SEC Form 8-K] [Myovant Sciences Ltd. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/myovant-sciences-ltd-filed-sec-form-8-k-completion-of-acquisition-4184816)
- 2023-03-01 13:18 UTC [SEC Form 8-K] [Myovant Sciences Ltd. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/myovant-sciences-ltd-filed-sec-form-8-k-submission-of-matters-4140956)
- 2023-02-17 21:29 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-myovant-sciences-ltd-4084517)
- 2023-02-16 22:01 UTC [SEC Form SC 13E3/A filed by Myovant Sciences Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-myovant-sciences-ltd-amendment-4079525)
- 2023-02-16 21:38 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-myovant-sciences-ltd-4079239)
- 2023-02-14 21:17 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Myovant Sciences Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-myovant-sciences-ltd-amendment-4063703)
- 2023-02-09 19:25 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Myovant Sciences Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-myovant-sciences-ltd-amendment-4033233)
- 2023-02-09 12:57 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-myovant-sciences-ltd-4027940)
- 2023-02-06 19:36 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Myovant Sciences Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-myovant-sciences-ltd-amendment-4009031)
- 2023-02-02 21:05 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-myovant-sciences-ltd-3996382)
- 2023-01-26 21:22 UTC [Market Chatter] [Myovant Sciences Q3 Sales $100.20M Miss $102.36M Estimate](https://www.quantisnow.com/insight/myovant-sciences-q3-sales-10020m-miss-10236m-estimate-3961425)
- 2023-01-26 21:13 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Myovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-myovant-sciences-ltd-3961226)
- 2023-01-26 21:06 UTC [SEC Form 8-K] [Myovant Sciences Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/myovant-sciences-ltd-filed-sec-form-8-k-results-of-operations-3961091)
- 2023-01-26 21:05 UTC [Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022](https://www.quantisnow.com/insight/myovant-sciences-announces-corporate-updates-and-financial-results-for-third-3961012)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MYOV
- Earnings history: https://www.quantisnow.com/earnings/MYOV
- Dividend history: https://www.quantisnow.com/dividends/MYOV
- Insider transactions: https://www.quantisnow.com/insiders/MYOV
- Options chain: https://www.quantisnow.com/options/MYOV
- SEC 8-K filings only: https://www.quantisnow.com/company/MYOV/8-k
- RSS and alerts for MYOV: https://www.quantisnow.com/docs/rss-feeds.md